News in Numbers

$51bn

According to a new report by Ernst & Young (EY), a 25% pharma tariff would add $51bn a year to US drug costs.

$900m

Amgen has announced plans to invest $900m to significantly expand its manufacturing facility in the US state of Ohio.

3%

According to a new paper in the American Journal of Preventive Medicine, an extra 10% intake of ultra-processed foods increases someone’s risk of dying before they reach 75 by 3%.

32%

Caribou Biosciences has decided to narrow its pipeline and reduce its workforce by approximately 32% amid continued challenges in the cell and gene therapy sector.

884

According to the Centers for Disease Control and Prevention, as of 24 April, there were 884 confirmed cases of measles across multiple US states.

Go to article: Home | The GLP-1 drug shortage is over. What’s next for the compounders?Go to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: MilliporeSigmaGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Molnar-Institute Company InsightGo to article: Molnar-InstituteGo to article: ZETAGo to article: In DepthGo to article: The GLP-1 drug shortage is over. What’s next for the compounders?Go to article: Big pharma faces headwinds in China as vaccine sales declineGo to article: How can pharma manage rising trial costs?Go to article: Can AI replace medical writers? Experts say not immediatelyGo to article: Saving shelved ultra-rare therapies through unorthodox fundingGo to article: Do in vivo CAR-T cell therapies have the potential to overtake ex vivo CAR-Ts?Go to article: Weight loss implants to increase compliance and cut admin burden for patientsGo to article: Greens Company InsightGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Buyer's GuidesGo to article: Next issue